Home/Terremoto Biosciences/James Christensen, Ph.D.

JC

James Christensen, Ph.D.

President, Head of Research & Development

Terremoto Biosciences

Therapeutic Areas

Oncology Genetic Disease

Terremoto Biosciences Pipeline

Drug	Indication	Phase
AKT1 Program	Cancer (Precision Oncology)	Phase 1

Leadership Team at Terremoto Biosciences

Charles Baum, M.D., Ph.D.

Chief Executive Officer

View full Terremoto Biosciences profile